Business / Finance

RSS

Landauer's revenues decrease 2.7% to $36.5 million in first fiscal quarter of 2016

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2016 first quarter ended December 31, 2015.

9 Feb 2016

Wayne State inks exclusive license agreement with TRImaran Pharma for novel class of drugs

Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.

9 Feb 2016

Study: Prior surgical abortion appears to increase risk of later preterm birth

Surgical methods used in a common form of abortion or to clear the womb after a spontaneous miscarriage appears to significantly increase the risk of a later preterm birth, say researchers at Thomas Jefferson University who analyzed 36 studies that enrolled more than 1 million women.

4 Feb 2016

Cell Therapy Catapult becomes Cell and Gene Therapy Catapult

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult.

4 Feb 2016

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

CANTEL MEDICAL CORP., has entered into a definitive agreement with North American Science Associates, Inc. to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million.

4 Feb 2016

Edwards Lifesciences' global sales grow 8.6% to $671.1 million in fourth quarter 2015

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2015.

3 Feb 2016

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.

3 Feb 2016

Hillenbrand acquires Red Valve for $131.9 million

Hillenbrand, Inc. has completed its previously announced acquisition of Red Valve Company, Inc. for a purchase price of $131.9 million in cash, including $3.3 million for related real estate.

2 Feb 2016

Aflac's total revenues decrease 3.5% to $5.3 billion in fourth quarter 2015

Aflac Incorporated today reported its fourth quarter results. Reflecting the weaker yen/dollar exchange rate, total revenues decreased 3.5% to $5.3 billion during the fourth quarter of 2015, compared with $5.5 billion in the fourth quarter of 2014. Net earnings were $730 million, or $1.71 per diluted share, compared with $703 million, or $1.57 per share, a year ago.

1 Feb 2016

FedMed gains access to Trovagene's Precision Cancer Monitoring tests and service

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that it has entered into an agreement with FedMed, Inc. establishing health benefit access to Trovagene's full line of Precision Cancer Monitoring (PCM) tests and services.

1 Feb 2016

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

HUYA Bioscience International President, CEO, Executive Chairman & Founder Dr. Mireille Gillings announced that Eisai Co., Ltd. has acquired from HUYA an exclusive license agreement for HBI-8000 in Japan, South Korea, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Singapore.

1 Feb 2016

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.

30 Jan 2016

Refugee women have higher risk of giving birth too early than non-refugee immigrants

Refugee women who come to Canada have greater risk of giving birth prematurely than non-refugee immigrants, a study by a St. Michael's Hospital researcher has found. Those risks are fueled by the fact that the preterm birth rate was 7.1 per cent among secondary refugees - those who spent more than six months in a transit country before arriving in Canada -compared to five per cent among secondary, non-refugee immigrants.

29 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

SCIO Health Analytics announces acquisition of Clear Vision Information Systems

SCIO Health Analytics today announced it has acquired Clear Vision Information Systems of Westlake Village, California, creators of an analytics solution and services suite that provides risk adjustment and quality metric strategies for health plans and providers.

27 Jan 2016

Halozyme closes $150 million royalty-backed debt transaction

Halozyme Therapeutics, Inc. today announced that it has closed the previously announced $150 million royalty-backed debt transaction with investment funds managed by Pharmakon Advisors and Athyrium Capital Management. The debt is secured by future royalties of ENHANZE products, received only from Halozyme's collaborations with Roche and Baxalta.

27 Jan 2016

Prime Healthcare Services closes $700 million senior secured credit facility

Prime Healthcare Services, Inc. today announced that it has closed a $700 million senior secured credit facility ("Facility") lead jointly by Wells Fargo Bank, N.A. and Barclays Bank, PLC.

26 Jan 2016

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Perrigo Company plc announced today that it has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, LLC.

25 Jan 2016

Remaining Pentax Italia shares acquired by Pentax GmbH

PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market strengthens PENTAX Medical’s position in Italy and will bring enhanced customer and professional education services to its Italian customers.

From PENTAX Medical Company 22 Jan 2016

Abingworth announces closing of $105m clinical co-development fund

Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.

21 Jan 2016

Business / Finance

Landauer's revenues decrease 2.7% to $36.5 million in first fiscal quarter of 2016

Wayne State inks exclusive license agreement with TRImaran Pharma for novel class of drugs

Study: Prior surgical abortion appears to increase risk of later preterm birth

Cell Therapy Catapult becomes Cell and Gene Therapy Catapult

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

Edwards Lifesciences' global sales grow 8.6% to $671.1 million in fourth quarter 2015

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

Hillenbrand acquires Red Valve for $131.9 million

Aflac's total revenues decrease 3.5% to $5.3 billion in fourth quarter 2015

FedMed gains access to Trovagene's Precision Cancer Monitoring tests and service

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Refugee women have higher risk of giving birth too early than non-refugee immigrants

CosmosID announces $6M in Series B funding round

SCIO Health Analytics announces acquisition of Clear Vision Information Systems

Halozyme closes $150 million royalty-backed debt transaction

Prime Healthcare Services closes $700 million senior secured credit facility

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Remaining Pentax Italia shares acquired by Pentax GmbH

Abingworth announces closing of $105m clinical co-development fund

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News